| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.00K | 0.00 | 0.00 | 0.00 | 28.00K | 107.00K |
| Gross Profit | -536.00K | -540.00K | -413.00K | -249.00K | 3.00K | -51.00K |
| EBITDA | -15.37M | -14.36M | -4.67M | -3.31M | -3.26M | -1.73M |
| Net Income | -15.49M | -14.44M | -4.12M | -3.44M | -3.32M | -1.66M |
Balance Sheet | ||||||
| Total Assets | 11.85M | 9.68M | 24.51M | 29.37M | 6.03M | 4.40M |
| Cash, Cash Equivalents and Short-Term Investments | 1.83M | 327.00K | 8.47M | 15.29M | 480.00K | 3.34M |
| Total Debt | 708.00K | 824.00K | 737.00K | 858.00K | 1.37M | 470.00K |
| Total Liabilities | 3.05M | 3.27M | 3.55M | 4.20M | 6.38M | 2.20M |
| Stockholders Equity | 8.80M | 6.42M | 20.95M | 25.17M | -352.00K | 2.19M |
Cash Flow | ||||||
| Free Cash Flow | -7.02M | -8.88M | -6.80M | -11.78M | -2.84M | -1.11M |
| Operating Cash Flow | -6.90M | -5.89M | -2.35M | -7.17M | -2.10M | -713.00K |
| Investing Cash Flow | -854.00K | 3.73M | 3.06M | -19.61M | -596.00K | -197.00K |
| Financing Cash Flow | 5.58M | 18.00K | -24.00K | 28.09M | 241.00K | 2.84M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | £22.05M | -1.13 | -68.06% | ― | -60.76% | -230.39% | |
51 Neutral | £129.16M | -4.98 | -86.37% | ― | 732.03% | 12.60% | |
47 Neutral | £22.59M | -0.83 | -113.32% | ― | ― | ― | |
44 Neutral | £390.80M | -12.63 | -18.47% | ― | 57.73% | -67.12% | |
44 Neutral | £12.33M | -36.88 | -20.52% | ― | ― | ― | |
41 Neutral | £19.00M | -3.31 | -87.07% | ― | 3.87% | -160.00% |
Clean Power Hydrogen plc has appointed Turner Pope Investments as joint broker, joining existing adviser Cavendish Capital Markets, in a move aimed at strengthening the company’s engagement with the stock market and improving the marketability of its shares. The decision underscores CPH2’s efforts to enhance its capital markets profile and investor communications as it seeks to commercialise its membrane-free electrolyser technology and pursue its strategy in the growing green hydrogen sector.
The most recent analyst rating on (GB:CPH2) stock is a Hold with a £5.50 price target. To see the full list of analyst forecasts on Clean Power Hydrogen PLC stock, see the GB:CPH2 Stock Forecast page.
Clean Power Hydrogen PLC (CPH2) has announced reaching a key milestone with the successful completion of the Level 1 Factory Acceptance Test for its next-generation MFE220 1MW unit. The electrolyser, which delivers medical-grade purity for hydrogen and oxygen, enables entry into new markets like semiconductors, data centers, and pharmaceuticals. This milestone has also facilitated the company’s decision to progress engineering design for a 5MW system, aiming for industry-leading efficiency. By focusing on decentralized ‘behind the meter’ solutions—such as grid support, renewable energy integration, and niche industrial uses—CPH2 positions itself as a cost-effective green hydrogen provider, ready to seize growing global demand with valuable potential to bypass reliance on government subsidies.
Clean Power Hydrogen PLC announced that its Chief Commercial Officer, Richard Scott, will present at the Mello2025 investor event on November 19th in London. This presentation is an opportunity for CPH2 to showcase its innovative hydrogen production technology to potential investors, potentially enhancing its market presence and attracting stakeholder interest.